SM-Youtube

1

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.

Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M. Tap J, et al. Among authors: simren m. Gastroenterology. 2017 Jan;152(1):111-123.e8. doi: 10.1053/j.gastro.2016.09.049. Epub 2016 Oct 7. Gastroenterology. 2017. PMID: 27725146 Free article.

2

Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern.

Simrén M, Abrahamsson H, Svedlund J, Björnsson ES. Simrén M, et al. Scand J Gastroenterol. 2001 May;36(5):545-52. doi: 10.1080/003655201750153476. Scand J Gastroenterol. 2001. PMID: 11346211

3

Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome.

Simrén M, Stotzer PO, Sjövall H, Abrahamsson H, Björnsson ES. Simrén M, et al. Eur J Gastroenterol Hepatol. 2003 Jan;15(1):55-62. doi: 10.1097/00042737-200301000-00010. Eur J Gastroenterol Hepatol. 2003. PMID: 12544695

4

Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome.

Simrén M, Ringström G, Björnsson ES, Abrahamsson H. Simrén M, et al. Psychosom Med. 2004 Mar-Apr;66(2):233-8. doi: 10.1097/01.psy.0000116964.76529.6e. Psychosom Med. 2004. PMID: 15039508 Clinical Trial.

5

Quality of life and illness costs in irritable bowel syndrome.

Simrén M, Brazier J, Coremans G, Dapoigny M, Müller-Lissner SA, Pace F, Smout AJ, Stockbrügger RW, Vatn MH, Whorwell PJ. Simrén M, et al. Digestion. 2004;69(4):254-61. doi: 10.1159/000079846. Epub 2004 Jul 14. Digestion. 2004. PMID: 15256832 Review.

6

High interdigestive and postprandial motilin levels in patients with the irritable bowel syndrome.

Simrén M, Björnsson ES, Abrahamsson H. Simrén M, et al. Neurogastroenterol Motil. 2005 Feb;17(1):51-7. doi: 10.1111/j.1365-2982.2004.00582.x. Neurogastroenterol Motil. 2005. PMID: 15670264 Clinical Trial.

7

A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome.

Ohman L, Isaksson S, Lundgren A, Simrén M, Sjövall H. Ohman L, et al. Among authors: simren m. Clin Gastroenterol Hepatol. 2005 Oct;3(10):980-6. doi: 10.1016/s1542-3565(05)00410-6. Clin Gastroenterol Hepatol. 2005. PMID: 16234043 Clinical Trial.

8

Inflammation as a cause of functional bowel disorders.

Törnblom H, Abrahamsson H, Barbara G, Hellström PM, Lindberg G, Nyhlin H, Ohlsson B, Simrèn M, Sjölund K, Sjövall H, Schmidt PT, Ohman L; SWEDISH MOTILITY GROUP. Törnblom H, et al. Among authors: simren m. Scand J Gastroenterol. 2005 Oct;40(10):1140-8. doi: 10.1080/00365520510023657. Scand J Gastroenterol. 2005. PMID: 16265771 Review. No abstract available.

9

Hypnosis for irritable bowel syndrome: the quest for the mechanism of action.

Simrén M. Simrén M. Int J Clin Exp Hypn. 2006 Jan;54(1):65-84. doi: 10.1080/00207140500327239. Int J Clin Exp Hypn. 2006. PMID: 16316884 Review.

10

Functional findings in irritable bowel syndrome.

Posserud I, Ersryd A, Simrén M. Posserud I, et al. Among authors: simren m. World J Gastroenterol. 2006 May 14;12(18):2830-8. doi: 10.3748/wjg.v12.i18.2830. World J Gastroenterol. 2006. PMID: 16718806 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

406 results

Search Page

Filters

My NCBI Filters

Search Results

406 results